mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.2 |
0.0002 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.0008 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |